Mathematical oncology: A new frontier in cancer biology and clinical decision making: Comment on "Improving cancer treatments via dynamical biophysical models" by M. Kuznetsov, J. Clairambault & V. Volpert.
Mathematical oncology: A new frontier in cancer biology and clinical decision making: Comment on "Improving cancer treatments via dynamical biophysical models" by M. Kuznetsov, J. Clairambault & V. Volpert.
复制标题
DOI:
10.1016/j.plrev.2021.11.005
复制
发表时间:
2022-03
影响因子:
11.7
通讯作者:
Enderling, Heiko
中科院分区:
文献类型:
--
作者:
Enderling, Heiko
In their comprehensive review, Kuznetsov, Claiambault and Volpert give a wonderful introduction into cancer biology and cancer therapy and the different mathematical modeling approaches that have been developed over the past decades [1]. Many investigators in numerous scientific disciplines have spent decades trying to decipher the mechanisms that drive the biology of carcinogenesis, tumor growth and progression, treatment response, and outcomes. Historically, experimentalists, clinicians, and quantitative scientists have not fully embraced interdisciplinary research, maybe due to lack of opportunity, maybe due to lack of understanding or compassion for the other fields. Cancer is a non-linear adaptive dynamic system, and to fully decipher this complexity we may need to look beyond molecular reductionism [2] towards the integration of physics, data science, mechanistic modeling and other emerging disciplines that have traditionally not been consulted in biomedical research. Kuznetsov, Clairambault and Volpert posit that mathematical and computational approaches are well-positioned to help detangle the cancer conundrum. The authors thoroughly introduce the different techniques for the different biological scales and discuss mathematical biology work that has helped gain new insights and generate new hypotheses from basic cancer biology to optimizing clinical oncology. A focus on disease dynamics, in a close dialogue between mathematical biology with routine statistical approaches and exciting new machine learning and artificial intelligence techniques, may help identify mechanisms that underly disease progression and treatment responses, and could yield new biomarkers and triggers for treatment adaptations.We have previously postulated that, for radiation oncology as an example, it is elusive to exhaustively evaluate every possible dose and dose fractionation, with and without the growing number of therapeutic agents, in different sequences and at all possible timings in vitro, in vivo, and clinically [3]. Mathematical modeling may provide the necessary tools to provide a mechanistic understanding of the many biological players and their interactions. Radiation biology and radiation oncology have had a long history of integrating
登录
查看更多内容
影响因子:
--
作者:
Zahid MU;Mohamed ASR;Caudell JJ;Harrison LB;Fuller CD;Moros EG;Enderling H
通讯作者:
Enderling H
影响因子:
2.1
作者:
Parsai, Shireen;Qiu, Richard L. J.;Scott, Jacob G.
通讯作者:
Scott, Jacob G.
DOI:
10.1093/imammb/dqw013
发表时间:
2017-12-01
影响因子:
1.1
作者:
Stocks, Theresa;Hillen, Thomas;Burger, Martin
通讯作者:
Burger, Martin
影响因子:
64.5
作者:
Leder K;Pitter K;LaPlant Q;Hambardzumyan D;Ross BD;Chan TA;Holland EC;Michor F
通讯作者:
Michor F
影响因子:
3.5
作者:
WEBB, S;NAHUM, AE
通讯作者:
NAHUM, AE